[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Vallet et al., 2008 - Google Patents

Percutaneous penetration and distribution of VX using in vitro pig or human excised skin: Validation of demeton-S-methyl as adequate simulant for VX skin permeation …

Vallet et al., 2008

Document ID
14372178129874917122
Author
Vallet V
Cruz C
Licausi J
Bazire A
Lallement G
Boudry I
Publication year
Publication venue
Toxicology

External Links

Snippet

The organophosphorus (OP) chemical warfare V agent O-ethyl-S-[2 (di-isopropylamino) ethyl] methyl phosphonothioate (VX), is a highly toxic compound which mainly penetrates the body via percutaneous pathways. Hence, the following prerequisite: to ascertain …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/96—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetic or similar toilet preparations characterised by the composition containing material, or derivatives thereof of undetermined constitution of vegetable origin, e.g. plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A61K8/30—Cosmetic or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Similar Documents

Publication Publication Date Title
Bartosova et al. Transdermal drug delivery in vitro using diffusion cells
Kanikkannan et al. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols
Rolland et al. Human scalp permeability to the chemical warfare agent VX
Schreiber et al. Reconstructed epidermis versus human and animal skin in skin absorption studies
Godin et al. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models
Schroeder et al. Infrared radiation-induced matrix metalloproteinase in human skin: implications for protection
Vallet et al. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin: Validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations
Wagner et al. Interrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalents
Rolland et al. Hairy skin exposure to VX in vitro: effectiveness of delayed decontamination
Rozman et al. Simultaneous absorption of vitamins C and E from topical microemulsions using reconstructed human epidermis as a skin model
Thors et al. Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin
Sintov et al. Comparative percutaneous permeation study using caffeine-loaded microemulsion showing low reliability of the frozen/thawed skin models
Rubio et al. Barrier function of intact and impaired skin: percutaneous penetration of caffeine and salicylic acid
Caon et al. Evaluation of the transdermal permeation of different paraben combinations through a pig ear skin model
Chandra et al. Dermal toxicity studies: factors impacting study interpretation and outcome
Yousef et al. Mechanistic evaluation of hydration effects on the human epidermal permeation of salicylate esters
Thors et al. Improved skin decontamination efficacy for the nerve agent VX
Schlupp et al. Development and validation of an alternative disturbed skin model by mechanical abrasion to study drug penetration
Olkowska et al. Skin models for dermal exposure assessment of phthalates
Thors et al. In vitro human skin penetration model for organophosphorus compounds with different physicochemical properties
Hatanaka et al. In silico estimation of skin concentration following the dermal exposure to chemicals
Patil et al. Quantification of sodium lauryl sulfate penetration into the skin and underlying tissues after topical application—pharmacological and toxicological implications
Cao et al. In vitro human skin permeation and decontamination of diisopropyl methylphosphonate (DIMP) using Dermal Decontamination Gel (DDGel) and Reactive Skin Decontamination Lotion (RSDL) at different timepoints
Marquet et al. Capacity of an in vitro rat skin model to predict human dermal absorption: influences of aging and anatomical site
Wellner et al. Percutaneous absorption of aromatic amines–A contribution for human health risk assessment